Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2012
11/08/2012US20120282252 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes
11/08/2012US20120282251 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
11/08/2012US20120282250 Il-21 antagonists
11/08/2012US20120282249 Formulation for anti-alpha4beta7 antibody
11/08/2012US20120282248 Prevention and treatment of cerebral amyloid angiopathy
11/08/2012US20120282247 Methods and compositions involving protective staphylococcal antigens, such as ebh polypeptides
11/08/2012US20120282246 Compositions and methods for antibody and ligand identification
11/08/2012US20120282245 Biomarkers and assays for the treatment of cancer
11/08/2012US20120282223 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
11/08/2012US20120282220 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
11/08/2012US20120282218 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
11/08/2012US20120282217 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
11/08/2012US20120282211 Antibodies and conjugates for modulators of angiogenesis
11/08/2012US20120282184 Treatment of obesity
11/08/2012US20120282183 Prognostic,. screening and treatment methods and agents for treatment of metastasis and inflammation using 5t4 oncofoetal glycoprotein
11/08/2012US20120282179 Methods of Using C-Met Modulators
11/08/2012US20120282177 ROR1 as Therapeutic and Diagnostic Target
11/08/2012US20120282176 Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier
11/08/2012US20120282175 Methods for Increasing Efficacy of FOLR1 Cancer Therapy
11/08/2012US20120282174 Synergistic Anti-CD47 Therapy for Hematologic Cancers
11/08/2012US20120282173 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012US20120282168 Methods of sensitizing cancer to therapy-induced cytotoxicity
11/08/2012CA2838041A1 Methods for handling biological drugs containing living cells
11/08/2012CA2835109A1 Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals
11/08/2012CA2834900A1 Formulation for anti-.alpha.4.beta.7 antibody
11/08/2012CA2834867A1 Formulation for anti-.alpha.4.beta.7 antibody
11/08/2012CA2834850A1 Methods for treating prostate cancer
11/08/2012CA2834788A1 Cochleate compositions and methods of making and using same
11/08/2012CA2834776A1 Vascular disruption agents and uses thereof
11/08/2012CA2832871A1 Compositions for inhibiting masp-2 dependent complement activation
11/08/2012CA2831572A1 Ultrafiltration concentration of allotype selected antibodies for small-volume administration
11/07/2012EP2520654A1 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
11/07/2012EP2520652A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associates genes
11/07/2012EP2520648A1 Anti-iga1 antibody
11/07/2012EP2520590A2 Cross-species-specific binding domain
11/07/2012EP2520589A1 Anti-cd27 antibody
11/07/2012EP2520588A1 Dual variable domain immunoglobulin and uses thereof
11/07/2012EP2520582A1 Puumala virus full-length M segment-based DNA vaccines
11/07/2012EP2520311A2 Method of treating hemolytic disease
11/07/2012EP2520310A1 Cellular permissivity factor for viruses, and uses thereof
11/07/2012EP2519636A1 Production of hemagglutinin-neuraminidase protein in microalgae
11/07/2012EP2519627A2 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages
11/07/2012EP2519544A1 Polypeptide heterodimers and uses thereof
11/07/2012EP2519543A1 Heterodimer binding proteins and uses thereof
11/07/2012EP2519542A1 Anti-cdh3 antibodies and uses thereof
11/07/2012EP2519541A1 Ron binding constructs and methods of use thereof
11/07/2012EP2519539A2 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
11/07/2012EP2519266A2 Infectious dna vaccines against chikungunya virus
11/07/2012EP2519265A2 Polysaccharide immunogens conjugated to e. coli carrier proteins
11/07/2012EP2519262A2 Antibody formulation
11/07/2012EP2519260A2 Novel modulators of trail signalling
11/07/2012EP2519259A1 Agonists of tlr4 and 9 receptors for preventing septic complications of post-traumatic immune depression in patients hospitalized for severe trauma
11/07/2012EP2519258A2 Recombinant ndv antigen and uses thereof
11/07/2012EP2519257A2 Atoxic recombinant holotoxins of clostridium difficile as immunogens
11/07/2012EP2519256A2 Probiotic bifidobacterial composition in accordance with secretor blood group status
11/07/2012EP2519255A2 Probiotic bifidobacterial composition in accordance with secretor blood group status
11/07/2012EP2519254A2 Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof
11/07/2012EP2519253A2 Inhibitors of vascular endothelial growth factor (vegf) receptors and methods of use thereof
11/07/2012EP2519252A1 Pythium immunotherapy
11/07/2012CN1961004B Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
11/07/2012CN1911960B Chlamydia protein, gene sequence and uses thereof
11/07/2012CN1524088B A virus causing respiratory tract illness in susceptible mammals
11/07/2012CN1505525B Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/07/2012CN102770554A Antibody glycosylation variants
11/07/2012CN102770537A Polypeptide modification method for purifying polypeptide multimers
11/07/2012CN102770457A Antigen presenting cell targeted vaccines
11/07/2012CN102770456A Multispecific antibodies, antibody analogs, compositions, and methods
11/07/2012CN102770454A Activatable constructs
11/07/2012CN102770453A Anti-FLT3 antibodies and methods of using the same
11/07/2012CN102770452A An IgY for a PA-MSHA bacterial strain, and preparation method and application thereof
11/07/2012CN102770451A Dual variable domain immunoglobulins and uses thereof
11/07/2012CN102770444A Immunogenic proteins and compositions
11/07/2012CN102770443A Detoxified escherichia coli immunogens
11/07/2012CN102770158A Antibody formulation
11/07/2012CN102770157A Formulations of antibody
11/07/2012CN102770156A Codon-optimzed hepatitis b virus core antigen (HBCAG)
11/07/2012CN102770155A Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
11/07/2012CN102770154A Probiotic bifidobacterial composition in accordance with secretor blood group status
11/07/2012CN102770016A Highly pathogenic avian influenza virus protein vaccine derived from transgenic plants, and method for preparing same
11/07/2012CN102766640A Method for preparing influenza A virus full-length M2 protein
11/07/2012CN102766606A Method for replicating influenza virus in culture
11/07/2012CN102766605A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
11/07/2012CN102766604A Swine influenza virus strain and application thereof
11/07/2012CN102766603A Chicken Newcastle disease virus and its separation method
11/07/2012CN102766210A Human CTLA-4 antibodies and their uses
11/07/2012CN102766195A Monoclonal antibody recongnizing epitope for HCV (hepatitis C virus) NS3 helicase ATP (adenosine triphosphate) binding site
11/07/2012CN102764436A Treatment of TNF alpha related disorders
11/07/2012CN102764435A Porcine Asian type-I foot-and-mouth disease virus inactivated vaccine adjuvant and preparation method thereof
11/07/2012CN102764434A Preparation method of animal immunopotentiator and application thereof
11/07/2012CN102764433A Prawn white spot syndrome virus multivalent vector vaccine and application thereof
11/07/2012CN102764432A Chinese giant salamander viral hemorrhagic disease cell culture-based inactivated vaccine, its preparation method and application thereof
11/07/2012CN102764431A Swine mycoplasmal pneumonia atomized live vaccine and preparation and inspection method thereof
11/07/2012CN102764430A Nasal spraying mucosa immunizing vaccine composition and preparation method thereof
11/07/2012CN102764425A Peptide selection method
11/07/2012CN102100909B Preparation method of loach vibrio cholerae vaccine
11/07/2012CN102018958B Method for removing hybrid protein and host DNA from vaccine product
11/07/2012CN101991863B Double-target DNA vaccine and constructing method thereof
11/07/2012CN101980705B Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
11/07/2012CN101948546B Fusion protein SAmB as well as coding gene and applications thereof
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 1823